Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Feldt-Rasmussen

Showing results (271-280 of 342) with videos related to

Pageof 35
Sort By:
American Journal of Medical Genetics. Part A|March 29, 2019
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT studyDerralynn A Hughes, Kathleen Nicholls, Gere Sunder-Plassmann, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2015
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomideDaniel Bengtsson, Henrik Daa Schrøder, Marianne Andersen, et al.
Journal of Medical Genetics|December 21, 2022
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomesDerralynn A Hughes, Daniel G Bichet, Roberto Giugliani, et al.
European Journal of Endocrinology|April 19, 2014
Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paperLuca Giovanella, Penelope M Clark, Luca Chiovato, et al.
Journal of Neuroendocrinology|August 11, 2023
Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomographyMaha Said, Jesper Krogh, Ulla Feldt-Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2014
Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysisNicholas A Tritos, Gudmundur Johannsson, Márta Korbonits, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2008
Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune diseaseLaura Agate, Stefano Mariotti, Rossella Elisei, et al.
Molecular Genetics and Metabolism Reports|March 4, 2022
Hearing loss in fabry disease: A 16 year follow-up study of the Danish nationwide cohortPuriya Daniel Würtz Yazdanfard, Grigoris Effraimidis, Christoffer Valdorff Madsen, et al.
Plos One|March 18, 2016
Phthalates Are Metabolised by Primary Thyroid Cell Cultures but Have Limited Influence on Selected Thyroid Cell Functions In VitroJuliana Frohnert Hansen, Marianne Møller Brorson, Malene Boas, et al.
Thyroid : Official Journal of the American Thyroid Association|March 11, 2003
Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid diseaseZubair Baloch, Pierre Carayon, Bernard Conte-Devolx, et al.
Pageof 35

Showing results (271-280 of 342) with videos related to

Sort By:
Pageof 35
American Journal of Medical Genetics. Part A|March 29, 2019
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT studyDerralynn A Hughes, Kathleen Nicholls, Gere Sunder-Plassmann, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2015
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomideDaniel Bengtsson, Henrik Daa Schrøder, Marianne Andersen, et al.
Journal of Medical Genetics|December 21, 2022
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomesDerralynn A Hughes, Daniel G Bichet, Roberto Giugliani, et al.
European Journal of Endocrinology|April 19, 2014
Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paperLuca Giovanella, Penelope M Clark, Luca Chiovato, et al.
Journal of Neuroendocrinology|August 11, 2023
Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomographyMaha Said, Jesper Krogh, Ulla Feldt-Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2014
Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysisNicholas A Tritos, Gudmundur Johannsson, Márta Korbonits, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2008
Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune diseaseLaura Agate, Stefano Mariotti, Rossella Elisei, et al.
Molecular Genetics and Metabolism Reports|March 4, 2022
Hearing loss in fabry disease: A 16 year follow-up study of the Danish nationwide cohortPuriya Daniel Würtz Yazdanfard, Grigoris Effraimidis, Christoffer Valdorff Madsen, et al.
Plos One|March 18, 2016
Phthalates Are Metabolised by Primary Thyroid Cell Cultures but Have Limited Influence on Selected Thyroid Cell Functions In VitroJuliana Frohnert Hansen, Marianne Møller Brorson, Malene Boas, et al.
Thyroid : Official Journal of the American Thyroid Association|March 11, 2003
Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid diseaseZubair Baloch, Pierre Carayon, Bernard Conte-Devolx, et al.
Pageof 35